Lyribea Capsule 300mg (Pregabalin)

Adult dose

This medication is to be taken orally, divided into two doses per day, regardless of food. 1. Neuropathic Pain - Peripheral neuropathic pain: The starting dose is 150 mg per day, which may be increased to 300 mg after 3-7 days, and if needed, it can be increased to a maximum of 600 mg at 7-day intervals. - Central neuropathic pain: The starting dose is 150 mg per day, which may be increased to 300 mg after one week.

Child dose

Administration is not recommended for children under 12 years of age and adolescents aged 12-17 due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behaviors; therefore, patients should consult a doctor immediately if they experience depression or mood changes during treatment. Patients with hypersensitivity to this medication or lactose intolerance should not take it. Diabetic patients may need to adjust their blood glucose control medications due to potential weight gain. If allergic reactions such as angioedema occur, medication should be discontinued immediately. Elderly patients should be particularly cautious during the early stages of treatment due to the risk of careless accidents from dizziness or drowsiness. Blurred vision or changes in vision may occur, and patients should consult a doctor if symptoms arise. Discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off according to a doctor's instructions. There is a risk of drug abuse; therefore, patients with a history of substance abuse should be monitored closely. Patients with impaired kidney function may require dose adjustments. Patients with heart disease should be closely monitored while taking this drug. Caution is advised when used with opioid analgesics due to the enhanced central nervous system depressive effects, which may lead to respiratory depression. During early pregnancy, there is a risk of fetal deformities, so this medication should be avoided during pregnancy, and fertile women should use effective contraception. Breastfeeding women should either avoid this medication or discontinue breastfeeding, as it may be transmitted through breast milk and affect the baby. Caution is required when driving or operating dangerous machinery due to the risks of dizziness and drowsiness. In case of overdose, symptoms such as confusion, drowsiness, or seizures may occur, and immediate medical attention is necessary. Keep this medicine out of the reach of children and avoid transferring it to other containers. If severe rashes or swelling occur on the skin during the course of this medication, discontinue usage immediately and consult a doctor.

Serious side effects

Hives, severe swelling, edema, chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes, jaundice, extreme lethargy, sudden and severe headaches, thunderclap headaches, seizures, confusion of consciousness, vision abnormalities, paralysis.

Mild side effects

• Dizziness
• drowsiness
• dry mouth
• increased appetite
• decreased appetite
• hypoglycemia
• confusion
• disorientation
• irritability
• depression

This medication should be stored in a tightly closed container to prevent air and moisture. A cool place with a temperature between 15 and 30 degrees Celsius is suitable for storage.

Appearance

Capsule with a reddish-brown upper part and a white lower part containing white or light yellow powder.

Package unit

30 capsules/bottle, 100 capsules/bottle